Impact of moderate alcohol consumption on hepatic fibrosis progression in HCV-infected patients

被引:0
|
作者
Barjoan, E. Marine
Gelsi, E.
Delasalle, P.
Ibragimova, N.
Sattonnet, C.
Saint-Paul, M. C.
Gueyffier, C.
Diebolt, E.
Hayek, R.
Fuzibet, J. G.
Ouzan, D.
Tran, A.
机构
[1] Univ Hosp, Liver Unit, Nice, France
[2] Univ Hosp, HCV Cote Azur Network, Nice, France
[3] Univ Hosp, Dept Pathol, Nice, France
[4] Gen Hosp, Dept Gastroenterol, Cannes, France
[5] Gen Hosp, Dept Gastroenterol, Menton, France
[6] Univ Hosp, Dept Internal Med, Nice, France
[7] A Tzank Inst, St Laurent Du Var, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
731
引用
收藏
页码:S275 / S276
页数:2
相关论文
共 50 条
  • [1] Similar Progression of Fibrosis Between HIV/HCV-Infected and HCV-Infected Patients: Analysis of Paired Liver Biopsy Samples
    Sterling, Richard K.
    Wegelin, Jacob A.
    Smith, Paula G.
    Stravitz, R. Todd
    Luketic, Velimir A.
    Fuchs, Michael
    Puri, Puneet
    Shiffman, Mitchell L.
    Contos, Melissa A.
    Mills, A. Scott
    Sanyal, Arun J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (12) : 1070 - 1076
  • [2] Factors associated with fibrosis progression in HCV-infected children in Egypt
    El-Hawary, M.
    El-Raziky, M.
    Esmat, G.
    Soliman, H.
    Abouzied, A.
    El-Raziky, M.
    El-Akel, W.
    El-Sayed, R.
    Shebl, F.
    Shaheen, A.
    El-Karaksy, H.
    LIVER INTERNATIONAL, 2006, 26 : 111 - 111
  • [3] HEPATIC NUCLEAR RECEPTOR-MEDIATED PATHWAYS IN STEATOSIS AND FIBROSIS IN HCV-INFECTED PATIENTS
    Wu, Chuanghong
    Gilroy, Richard
    Damjanov, Ivan
    O'Neil, Maura
    Taylor, Ryan
    Wan, Yu-Jui Yvonne
    HEPATOLOGY, 2011, 54 : 1334A - 1334A
  • [4] INTERLEUKIN-6 IS ASSOCIATED WITH LIVER FIBROSIS IN HCV-INFECTED PATIENTS WITH ALCOHOL ABUSE
    Silva, L. D.
    Giampietro, Y. G. G.
    Theobaldo, B. D. M.
    da Cunha, L. R.
    Teixeira, R.
    Rocha, G. A.
    Queiroz, D. M. D. M.
    Martins Filho, O. A.
    Neves, F. S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S604 - S604
  • [5] Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders
    van de Putte, D. E. Fransen
    Fischer, K.
    De Knegt, R. J.
    Posthouwer, D.
    Van Erpecum, K. J.
    Mauser-Bunschoten, E. P.
    HAEMOPHILIA, 2011, 17 (05) : E975 - E980
  • [6] WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients
    Liu, Yanhong
    El-Serag, Hashem B.
    Jiao, Li
    Lee, JuSeog
    Moore, David
    Franco, Luis M.
    Tavakoli-Tabasi, Shahriar
    Tsavachidis, Spiridon
    Kuzniarek, Jill
    Ramsey, David J.
    White, Donna L.
    PLOS ONE, 2013, 8 (12):
  • [8] THE CLINICAL AND ECONOMIC IMPACT OF HCV TREATMENT ON NON-HEPATIC CANCERS AMONG HCV-INFECTED PATIENTS
    Wang, W.
    Lo Re, V
    Guo, Y.
    Xiao, H.
    Brown, J.
    Park, H.
    VALUE IN HEALTH, 2019, 22 : S36 - S36
  • [9] TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients
    Resino, Salvador
    Fernandez-Rodriguez, Amanda
    Pineda-Tenor, Daniel
    Gomez-Moreno, Ana Zaida
    Sanchez-Ruano, Juan Jose
    Artaza-Varasa, Tomas
    Munoz-Gomez, Maria Jose
    Virseda-Berdices, Ana
    Martin-Vicente, Maria
    Martinez, Isidoro
    Jimenez-Sousa, Maria A.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (03) : 1 - 10
  • [10] Mild-moderate alcohol consumption does not enhance liver fibrosis progression in patients with chronic hepatitis C virus (HCV)
    Cheung, O
    Salvatore, J
    Hubbard, S
    Sterling, RK
    Luketic, VA
    Stravitz, TR
    Sanyal, AJ
    Mills, SA
    Contos, MJ
    Shiffman, ML
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S113 - S114